Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2014

Open Access 01-07-2014 | Original Paper

A Review of the Evidence of Harm from Self-Tests

Authors: Annette N. Brown, Eric W. Djimeu, Drew B. Cameron

Published in: AIDS and Behavior | Special Issue 4/2014

Login to get access

Abstract

Although HIV self-testing may overcome some barriers to HIV testing, various stakeholders have expressed concerns that HIV self-testing may lead to unintended harm, including psychological, social and medical harm. Recognizing that similar concerns were raised in the past for some other self-tests, we conduct a review of the literature on a set of self-tests that share some characteristics with HIV self-tests to determine whether there is any evidence of harm. We find that although the potential for harm is discussed in the literature on self-tests, there is very little evidence that such harm occurs.
Literature
1.
Sabapathy K, Van den Bergh R, Fidler S, Hayes R, Ford N. Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2012;9(12):e1001351.PubMedCentralPubMedCrossRef
2.
Suthar AB, Ford N, Bachanas PJ, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med. 2013;10(8):e1001496.PubMedCentralPubMedCrossRef
3.
Kennedy CE, Fonner VA, Sweat MD, Okero FA, Baggaley R, O’Reilly KR. Provider-initiated HIV testing and counseling in low- and middle-income countries: a systematic review. AIDS Behav. 2013;17(5):1571–90.PubMedCentralPubMedCrossRef
4.
5.
6.
7.
8.
Spielberg F, Levine RO, Weaver M. Self-testing for HIV: a new option for HIV prevention? Lancet Infect Dis. 2004;4(10):640–6.PubMedCrossRef
9.
PantPai N, Klein MB. Are we ready for home-based, self-testing for HIV? Futur HIV Ther. 2008;2(6):515–20.CrossRef
10.
11.
Posluszny DM, McFeeley S, Hall L, Baum A. Stress, breast cancer risk, and breast self-examination: chronic effects of risk and worry. J Appl Biobehav Res. 2004;9(2):91–105.CrossRef
12.
Kearney AJ. Increasing our understanding of breast self-examination: women talk about cancer, the health care system, and being women. Qual Health Res. 2006;16(6):802–20.PubMedCrossRef
13.
Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? a meta-analysis of the prospective evidence. Prev Med. 2006;42(6):401–8.PubMedCrossRef
14.
Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2005. CA Cancer J Clin. 2005;55(1):31–44.PubMedCrossRef
15.
Beacham AO, Carpenter JS, Andrykowski MA. Impact of benign breast biopsy upon breast self-examination. Prev Med. 2004;38(6):723–31.PubMedCrossRef
16.
Danish SJ, Chopin SM, Conley K. Rethinking breast self-examinations: are we asking the right questions? Breast Cancer (Auckl). 2008;2:31–5.
17.
Brain K, Norman P, Gray J, Mansel R. Anxiety and adherence to breast self-examination in women with a family history of breast cancer. Psychosom Med. 1999;61(2):181–7.PubMedCrossRef
18.
19.
Absetz P, Aro AR, Sutton SR. Experience with breast cancer, pre-screening perceived susceptibility and the psychological impact of screening. Psychooncology. 2003;12(4):305–18.PubMedCrossRef
20.
Moulds A. The dangers of self-examination. Practitioner. 2000;244(1614):717.PubMed
21.
Tarrant M. Why are we still promoting breast self-examination? Int J Nurs Stud. 2006;43(4):519–23.PubMedCrossRef
22.
Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst. 2002;94(19):1445–57.PubMedCrossRef
23.
Katapodi MC, Lee KA, Facione NC, Dodd MJ. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med. 2004;38(4):388–402.PubMedCrossRef
24.
Moore P. Excessive breast self-examination may promote anxiety. Lancet. 1999;353(9158):1073.CrossRef
25.
Ceber E, Soyer MT, Ciceklioglu M, Cimat S. Breast cancer risk assessment and risk perception on nurses and midwives in Bornova Health District in Turkey. Cancer Nurs. 2006;29(3):244–9.PubMedCrossRef
26.
Spiegel TN, Hill KA, Warner E. The attitudes of women with BRCA1 and BRCA2 mutations toward clinical breast examinations and breast self-examinations. J Womens Health (Larchmt). 2009;18(7):1019–24.CrossRef
27.
Hussein DM, Alorf SH, Al-Sogaih YS, et al. Breast cancer awareness and breast self-examination in Northern Saudi Arabia: a preliminary survey. Saudi Med J. 2013;34(7):681–8.PubMed
28.
Nahcivan NO, Secginli S. Health beliefs related to breast self-examination in a sample of Turkish women. Oncol Nurs Forum. 2007;34(2):425–32.PubMedCrossRef
29.
Bilardi JE, Walker S, Read T, et al. Gay and bisexual men’s views on rapid self-testing for HIV. AIDS Behav. 2013;17(6):2093–9.PubMedCrossRef
30.
PantPai N, Sharma J, Shivkumar S, et al. Supervised and unsupervised self-testing for HIV in high- and low-risk populations: a systematic review. PLoS Med. 2013;10(4):e1001414.CrossRef
31.
Wilson DP, Fairley CK, Sankar D, et al. Replacement of conventional HIV testing with rapid testing: mathematical modeling to predict the impact on further HIV transmission between men. Sex Transm Infect. 2011;87(7):588–93.PubMedCrossRef
32.
Owen SM, Yang C, Spira T, et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol. 2008;46(5):1588–95.PubMedCentralPubMedCrossRef
33.
34.
Bavinton BR, Brown G, Hurley M, et al. Which gay men would increase their frequency of HIV testing with home self-testing? AIDS Behav. 2013;17(6):2084–92.PubMedCrossRef
Metadata
Title
A Review of the Evidence of Harm from Self-Tests
Authors
Annette N. Brown
Eric W. Djimeu
Drew B. Cameron
Publication date
01-07-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 4/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0831-y

Other articles of this Special Issue 4/2014

AIDS and Behavior 4/2014 Go to the issue

Original Paper

What Should the Ideal HIV Self-Test Look Like? A Usability Study of Test Prototypes in Unsupervised HIV Self-Testing in Kenya, Malawi, and South Africa

Original Paper

Factors Associated with Acceptability of HIV Self-Testing Among Health Care Workers in Kenya

Original Paper

Factors Shaping Initial Decision-Making to Self-test Amongst Cohabiting Couples in Urban Blantyre, Malawi

Original Paper

HIV Self-Testing in Resource-Limited Settings: Regulatory and Policy Considerations

Editorial Review

Realizing the Potential for HIV Self-Testing

Original Paper

Unsupervised Self-testing as Part Public Health Screening for HIV in Resource-Poor Environments: Some Ethical Considerations
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits